MAP2K7 and cancer: In a recent in vitro and animal study we demonstrated that BRAF/MEK inhibitors could induce strong therapeutic responses in cancer cells harboring both BRAF V600E and mutant TERT promoter through causing robust apoptosis but not cells harboring WT TERT (24).